Submit Manuscript    >>    Login | Register

Search

Search Result for Paul Milliez MD, PhD

Title: Adjunctive Vein of Marshall Ethanol Infusion During Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis

Credits: Mohammed Mhanna, Azizullah Beran, Ahmad Al-Abdouh, Omar Sajdeya, Mohammed Altujjar, ModarAlom, Abdelrhman M. Abumoawad, Ahmed M Elzanaty,Paul Chacko, Ehab A Eltahawy


Title: Atrial Fibrillation as a Presenting Symptom of Cardiac Sarcoid

Credits: Ali Hussain, Alvin C. Yiu, Uzoagu A. Okonkwo, John-paul O’shea


Title: Standardized Quantification of Vagal Denervation by Extracardiac Vagal Stimulation During Second Generation Cryoballoon Ablation: a Vein per Vein Analysis

Credits: Thiago Guimarães Osório, Gian-Battista Chierchia, Riccardo Maj, Hugo-Enrique Coutiño, Erwin Ströker, Juan Sieira, Francesca Salghetti, Muryo Terasawa, Paul-Adrian C?lburean, Alessandro Rizzo, Gianluca Borio, Oriana Scala, Alessio Galli, Pedro Brugada, Carlo de Asmundis


Title: Single Day Observational Experience at High Volume Ablation Programs: What is the Impact to Practicing Electrophysiologists?

Credits: Jose Osorio, Rosemary S Bubien, Jason D. Ruff, Andrew J. Brenyo, Anil Rajendra, Brett A. Gidney, Paul Zei, Gustavo X. Morales


Title: Leadless Pacemakers – Implant, Explant and Long-Term Safety and Efficacy Data

Credits: Krishna Kancharla, MD, Abhishek J. Deshmukh, MD, Paul A. Friedman, MD


Title: Use of Acoustic Cardiography Immediately Following Electrical Cardioversion to Predict Relapse of Atrial Fibrillation

Credits: Paul Erne, MD, Therese J Resink, PhD, Andrea Mueller, MD, Michael Coslovsky, PhD, Richard Kobza, MD, David Conen, MD, Peter Bauer, PhD, Patricia Arand, PhD.


Title: Reducing the risk of stroke in patients with nonvalvular atrial fibrillation with direct oral anticoagulants. Is one of these not like the others?

Credits: Paul P. Dobesh, John Fanikos


Title: Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation

Credits: Katy Lavoie, Marie-Hélène Turgeon, Caroline Brais, Josiane Larochelle, Lucie Blais, Paul Farand, Geneviève Letemplier, Sylvie Perreault, Marie-France Beauchesne


Title: The Cost Effectiveness of LAA Exclusion

Credits: Bahij Kreidieh, Moisés Rodríguez-Mañero, Sergio H. Ibarra-Cortez, Paul Schurmann, Miguel Valderrábano


Title: The Atrial Fibrillation Therapies after ER visit: Outpatient Care for Patients with Acute AF - The AFTER3 Study

Credits: Paul Angaran, MD, Zana Mariano, MA, CCRP, Vlad Dragan, BSc, Lily Zou, MSc, Clare L. Atzema, MD, MSc, Iqwal Mangat, MD, Paul Dorian, MD, MSc


Title: How To Identify Low LVEF Patients Most Likely To Benefit From Prophylactic ICD Therapy

Credits: Ian E. Mann, Amit Kaura, Paul A. Scott


Title: Effect of catheter ablation on quality of life in atrial fibrillation

Credits: Jorge Gonzalez, Laurent Macle, Marc W. Deyell, Matthew T. Bennett, Marc Dubuc, Katia Dyrda, Peter G. Guerra, Paul Khairy, Blandine Mondesert, Léna Rivard, Denis Roy, Mario Talajic, Bernard Thibault, Jason G. Andrade


Title: Atrial Fibrillation Ablation by the Epicardial Approach

Credits: Anil K Gehi, Andy C. Kiser, J. Paul Mounsey


Title: Utility of the pulmonary vein ablation catheter for electrical isolation of a left sided vena cava triggering atrial fibrillation

Credits: David Turpie, Chris Llewellyn, Paul Broadhurst


Title: Atrial Fibrillation and Stroke – Increasing Stroke Risk With Intervention

Credits: Christopher V. DeSimone, Malini Madhavan, Elisa Ebrille, Alejandro A. Rabinstein, Paul A. Friedman, Samuel J. Asirvatham


Title: Rate control in atrial fibrillation: Methods for assessment, targets for ventricular rate during AF, and clinical relevance for device therapy

Credits: Shantanu Sarkar, PhD, Paul D. Ziegler, MS


Title: Role of atrio-ventricular junction ablation in symptomatic atrial fibrillation for optimization of cardiac resynchronization therapy

Credits: Paul J. Garabelli, MD, Stavros Stavrakis, MD, PhD


Title: The Temporal Relationship between Atrial Fibrillation and Ischemic Stroke

Credits: Dr. Paul D. Ziegler


Title: Reversal of dilated cardiomyopathy after successful radio-frequency ablation of frequent atrial premature beats. A case of « atrial premature beat-related cardiomyopathy »

Credits: Paul Louis Vervueren, MD, Clement Delmas, MD, Mathieu Berry, MD, Anne Rollin, MD, Marie Sadron, MD, Alexandre Duparc, MD, Pierre Mondoly, MD, Benjamin Honton, MD, Olivier Lairez, MD, Philippe Maury, MD


Title: Outcome of Patients Discharged After Their First Detected Episode of Atrial Fibrillation

Credits: Sophie Gomes MD, Laure Champ-Rigot MD, Anthony Foucault MD, Arnaud Pellissier MD, Alain Lebon MD, Patrice Scanu MD, Paul Milliez MD, PhD


Title: Gender and Racial Characteristics of Patients Referred to a Tertiary Atrial Fibrillation Center

Credits: Pamela K. Mason, MD, Liza Moorman, RN, ACNP-BC, Douglas E. Lake, PhD, J. Michael Mangrum, MD, John P. DiMarco, MD, PhD, John D. Ferguson, MBChB, MD, Srijoy Mahapatra, MD, Kenneth C. Bilchick, MD, David Wiggins, BS, RN, J. Paul Mounsey, MD, PhD, J. Randall Moorman, MD


  • Dr. Paul A Scott, DM MRCP.

    Affiliation: Dr Paul A Scott is a Cardiac Electrophysiologist at King’s College Hospital, London. He undertook his electrophysiology training in Southampton, London and Vancouver Island. His clinical and research interests are centred around catheter ablation of atrial fibrillation and complex device therapy.

  • Dr. Paul Angaran, MD.

    Affiliation: Dr. Angaran is a cardiologist and electrophysiologist at St. Michael’s Hospital, Toronto, Canada. His research interests include clinical outcomes of patients with atrial fibrillation and ventricular tachycardia, particularly undergoing catheter ablation therapy, and implantable cardioverter defibrillators.

  • Dr. Paul Broadhurst, MD FRCP FESC FHRS.

    Affiliation: Paul Broadhurst MD FRCP FESC FHRS has been Consultant Cardiologist at Aberdeen Royal Infirmary and Honorary Senior Lecturer at the University of Aberdeen since 2002. He is a graduate of the University of Dundee and trained in cardiology at St Bartholomew's Hospital, London. His main clinical and research interests are in various aspects of clinical electrophysiology.

  • Dr. Paul D. Ziegler, MS.

    Affiliation: Cardiac Rhythm Disease Management Division, Medtronic Inc.

  • Dr. Paul P. Dobesh, Pharm.D.

    Affiliation: Dr. Dobesh is a Professor of Pharmacy Practice at the University of Nebraska Medical Center College of Pharmacy in Omaha, Nebraska, USA. Dr. Dobesh’s teaching and research interest include the areas of ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics. Dr. Dobesh has conducted research on antiplatelet and anticoagulant therapy, focusing on real-world utilization and health-economics. He has also published book chapters and several manuscripts in this area.

  • Dr. Srijoy Mahapatra, MD.

    Affiliation: St. Jude Medical, Inc., St. Paul, MN, USA.

  • Paul P. Dobesh, Pharm.D.

    Affiliation: Dr. Dobesh is a Professor of Pharmacy Practice at the University of Nebraska Medical Center College of Pharmacy in Omaha, Nebraska, USA. Dr. Dobesh’s teaching and research interest include the areas of ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics. Dr. Dobesh has conducted research on antiplatelet and anticoagulant therapy, focusing on real-world utilization and health-economics. He has also published book chapters and several manuscripts in this area.

  • Pawel Tomasz Matusik, .

    Affiliation: Pawel T. Matusik, M.D., Ph.D., has special medical and scientific interests in electrocardiology, geriatrics and basic sciences in cardiovascular medicine. He is a member of the European Society of Cardiology, European Heart Rhythm Association and "Club 30" of the Polish Cardiac Society.

  • Dr. Gilutz Harel, MD, FESC.

    Affiliation: Dr. Gilutz Harel received his M.D. degrees from Ben Gurion University of the Negev, Beer Sheva, Israel at 1980. He was appointed as a director of the intensive coronary cardiac care unit at 1995 at the Soroka University Medical Center, a 1000-bed tertiary care and university hospital, affiliated with the Ben-Gurion University. At 1996-97 he was a visiting professor at the cardiovascular division at Stanford University where he had training in IVUS (Paul Yock) and passively participated in the research group of John Cook).

  • Biosense Webster
    event date
    Introduction to AFib
    Ablation Specialist

    View Ablation Specialists